Related references
Note: Only part of the references are listed.CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies
Ashanty M. Melo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
YY1lo NKT cells are dedicated IL-10 producers
Patrick W. Darcy et al.
SCIENTIFIC REPORTS (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile
Danielle Krijgsman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor
Sourav Paul et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d
Katharine Clark et al.
FRONTIERS IN IMMUNOLOGY (2019)
Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy
Ying Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells
Y. Wang et al.
MUCOSAL IMMUNOLOGY (2018)
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma et al.
SCIENCE (2018)
Utilization of invariant natural killer T cells for gastric cancer treatment
Qi Xu et al.
FUTURE ONCOLOGY (2018)
Tissue-Specific Roles of NKT Cells in Tumor Immunity
Masaki Terabe et al.
FRONTIERS IN IMMUNOLOGY (2018)
Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice
Naveena B. Janakiram et al.
IMMUNOLOGY (2017)
A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies
Malgorzata Waldowska et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Hypercholesterolemia Increases Colorectal Cancer Incidence by Reducing Production of NKT and γδ T Cells from Hematopoietic Stem Cells
Guodong Tie et al.
CANCER RESEARCH (2017)
NKT cell subsets as key participants in liver physiology and pathology
Keya Bandyopadhyay et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer
Liu-sheng Peng et al.
ONCOTARGET (2016)
The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment
Sebastian Lundgren et al.
PLOS ONE (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The burgeoning family of unconventional T cells
Dale I. Godfrey et al.
NATURE IMMUNOLOGY (2015)
Regulation of NKT cell localization in homeostasis and infection
Drew Slauenwhite et al.
FRONTIERS IN IMMUNOLOGY (2015)
Metabolic Activation of lntrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
Monika Julia Wolf et al.
CANCER CELL (2014)
The immunoregulatory role of type I and type II NKT cells in cancer and other diseases
Masaki Terabe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response
Jie Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
NKT cell networks in the regulation of tumor immunity
Faith C. Robertson et al.
FRONTIERS IN IMMUNOLOGY (2014)
β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy
Jessica J. O'Konek et al.
CLINICAL CANCER RESEARCH (2013)
Combination of Intratumoral Invariant Natural Killer T Cells and Interferon-Gamma Is Associated with Prognosis of Hepatocellular Carcinoma after Curative Resection
Yong-Sheng Xiao et al.
PLOS ONE (2013)
Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells
Xiangshu Wen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
Daofeng Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Role of Natural Killer T Cells in the Mouse Colitis-Associated Colon Cancer Model
K. Yoshioka et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
Andrew J. Nicol et al.
CLINICAL CANCER RESEARCH (2011)
Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity
Jessica J. O'Konek et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
Gerhard Wingender et al.
JOURNAL OF IMMUNOLOGY (2010)
V alpha 24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Liping Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
Hyun-Jeong Ko et al.
JOURNAL OF IMMUNOLOGY (2009)
Enrichment of Human CD4+ Vα24/Vβ11 Invariant NKT Cells in Intrahepatic Malignant Tumors
Gabriel Bricard et al.
JOURNAL OF IMMUNOLOGY (2009)
Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma
Gourapura J. Renukaradhya et al.
BLOOD (2008)
Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-α2
Stefan Fichtner-Feigl et al.
CANCER RESEARCH (2008)
NKT cells in tumor immunity: Opposing subsets define a new immunoregulatory axis
Jay A. Berzofsky et al.
JOURNAL OF IMMUNOLOGY (2008)
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer
Tetsuro Uchida et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Antitumor effect of whole body hyperthermia with α-galactosylceramide in a subcutaneous tumor model of colon cancer
Takeshi Hattori et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2007)
Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis
Elena Ambrosino et al.
JOURNAL OF IMMUNOLOGY (2007)
Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
S. Nagaraj et al.
INTERNATIONAL IMMUNOLOGY (2006)
A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Increased intratumor Vα24-positive natural killer T cells:: A prognostic factor for primary colorectal carcinomas
T Tachibana et al.
CLINICAL CANCER RESEARCH (2005)
Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes
M Margalit et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
DH Chang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13
JM Park et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide
A Jahng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity
M Nieda et al.
BLOOD (2004)
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation
SI Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Going both ways: immune regulation via CD1d-dependent NKT cells
DI Godfrey et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function
DB Stetson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells
T Kenna et al.
JOURNAL OF IMMUNOLOGY (2003)
CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver
T Miyagi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
S Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo
JL Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human NKT cells express granulysin and exhibit antimycobacterial activity
JL Gansert et al.
JOURNAL OF IMMUNOLOGY (2003)
NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo
D Stober et al.
JOURNAL OF IMMUNOLOGY (2003)
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The unconventional lifestyle of NKT cells
M Kronenberg et al.
NATURE REVIEWS IMMUNOLOGY (2002)
A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas
NY Crowe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Impaired proliferative response of Vα24 NKT cells from cancer patients against α-galactosylceramide
K Yanagisawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining
JE Gumperz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Distinct functional lineages of human Vα-24 natural killer T cells
PT Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
MJ Smyth et al.
BLOOD (2002)
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
LS Metelitsa et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways
Y Hayakawa et al.
JOURNAL OF IMMUNOLOGY (2001)
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
M Terabe et al.
NATURE IMMUNOLOGY (2000)
NKT cells: facts, functions and fallacies
DI Godfrey et al.
IMMUNOLOGY TODAY (2000)
Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12
K Takeda et al.
INTERNATIONAL IMMUNOLOGY (2000)
Differential tumor surveillance by natural killer (NK) and NKT cells
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
MJ Smyth et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
